BioPortfolio Biotechnology Pharmaceutical Healthcare Medical Life Science Drug Discovery Disease
BioNews
Biotechnology, Pharmaceutical, Life Science & Medical News
Track this topic with BioWatch News Alerts: Register | Login
search help

Search Results

Documents 1-5 out of 5 found
  Current Search:  abreva: 5     

HTML
100%
alli(TM) Partners with Breast Cancer Network of Strength(TM) to Support Women Challenged by Breast Cancer, Wei
Research Indicates Being Overweight Increases Risk of Breast Cancer PARSIPPANY, N.J., Sept.

22 /PRNewswire/ -- Who knew that simply putting on 21 - 30 pounds between your teens and your 50s could increase your risk of breast cancer after...

PR Newswire via Yahoo!:  Sep 22 2008 9:40AM
Matching: abreva
Find similar documents
HTML
100%
New cold sore treatments combat 100 million outbreaks in U.S. each year
Roughly 20 percent to 40 percent of adult suffer recurrent outbreaks of cold sores.

About 100 million episodes of recurrent cold sores occur in the United States alone.

Currently there is no cure, but several symptomatic treatments are...

Drugtopics.com:  Sep 17 2008 9:10PM
Matching: abreva
Find similar documents
HTML
100%
News: New cold sore treatments combat 100 million outbreaks in U.S. each year
Roughly 20 percent to 40 percent of adult suffer recurrent outbreaks of cold sores.

About 100 million episodes of recurrent cold sores occur in the United States alone.

Currently there is no cure, but several symptomatic treatments are...

Drugtopics.com:  Sep 15 2008 11:12PM
Matching: abreva
Find similar documents
HTML
100%
30th Hybritech reunion marks biotech's genesis
CARMEL VALLEY What do successful science nerds talk about at a reunion?

Kids, grandkids and the industry, sure?

But yesterday there also was giddy remembrance of the quirky early days at Hybritech, the company considered the grandfather...

SignOn San Diego:  Sep 14 2008 11:11AM
Matching: abreva
Find similar documents
HTML
100%
AVANIR Pharmaceuticals Wall Street Analyst Forum Presentation Transcript
AVANIR's lead product candidate Zenvia is in the late stage of development for two different diseases states.

Without giving an overly lengthy introduction to the company, I'll let them do their PowerPoint presentation themselves, I would...

Seeking Alpha:  Sep 10 2008 7:56PM
Matching: abreva
Find similar documents

 

Nothing in this website should be used in place of personal medical advice from your own qualified medical practitioner.  See User Agreement

Send comments and feedback to:
Peter Barfoot Managing Director, BioPortfolio Ltd.
UK Tel: (+44) 1300 321501
USA Voicemail and Fax: (+1) 415 680 2472

All rights reserved. All other trademarks recognized.

BioPortfolio Limited is registered in England & Wales at Wessex Barn, Dorchester Road, Frampton, Dorset, DT2 9NB, UK. No.3312883 VAT No. GB 744 6483 10

Copyright © 1997-2008 - BioPortfolio Limited.